CytoMed Therapeutics’ (NASDAQ:GDTC – Get Free Report) lock-up period will end on Wednesday, October 11th. CytoMed Therapeutics had issued 2,412,369 shares in its public offering on April 14th. The total size of the offering was $9,649,476 based on an initial share price of $4.00. After the end of CytoMed Therapeutics’ lock-up period, restrictions preventing company […]
CytoMed Therapeutics’ (NASDAQ:GDTC – Get Free Report) lock-up period is set to end on Wednesday, October 11th. CytoMed Therapeutics had issued 2,412,369 shares in its initial public offering on April 14th. The total size of the offering was $9,649,476 based on an initial share price of $4.00. After the end of CytoMed Therapeutics’ lock-up period, […]
CytoMed Therapeutics Limited (NASDAQ: GDTC) ("CytoMed" or "Company"), a Singapore-based biopharmaceutical company focused on harnessing its proprietary technologies to develop novel donor-derived cell-based allogeneic immunotherapies for the treatment of various cancers, today announced that its exclusively licensed induced pluripotent stem cell (iPSC)-based technology has been granted a patent by the China National Intellectual Property Administration (CNIPA).
CytoMed Expands Research Collaboration into China After Entering Into MOU baltimorestar.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from baltimorestar.com Daily Mail and Mail on Sunday newspapers.